文献速递鼻科

嗅裂黏液嗜酸性粒细胞来源神经毒素比血嗜酸性粒细胞计数更能反映慢性鼻窦炎患者的嗅觉丧失

Olfactory cleft mucus eosinophil-derived neurotoxin better reflects olfactory loss than blood eosinophil counts in patients with chronic rhinosinusitis.
PubMed 文献 · Int Forum Allergy Rhinol · 2023-06-12

该前瞻性研究纳入150例接受内镜鼻窦手术的慢性鼻窦炎(CRS)患者和25例健康对照,检测上鼻甲活检组织与嗅裂黏液的嗜酸性粒细胞来源神经毒素(EDN)水平,并结合Sniffin' Sticks测试、嗅裂CT评分与嗅裂内镜量表(OCES)评估。结果发现伴嗅觉障碍的CRS患者嗅黏膜与嗅裂黏液EDN水平显著更高,黏液EDN与多项嗅觉指标相关,且在校正人口学与共病后仍与嗅觉障碍显著相关(OR=2.162,P=0.027)。黏液EDN预测嗅觉障碍的曲线下面积显著优于血嗜酸性粒细胞计数(0.873 vs 0.764,P=0.024)。结论认为嗅裂黏液EDN可能比血嗜酸性粒细胞计数更好的预测CRS嗅觉障碍的生物标志物。

要点

  • 伴嗅觉障碍的CRS患者嗅黏膜EDN(P=0.016)与嗅裂黏液EDN(P<0.001)显著高于无嗅觉障碍者。
  • 黏液EDN与血嗜酸性粒细胞(r=0.625,P=0.002)、嗅裂CT评分(r=0.738,P<0.001)、OCES(r=0.605,P=0.004)正相关。
  • 黏液EDN预测嗅觉障碍的AUC为0.873,显著优于血嗜酸性粒细胞计数的0.764(P=0.024)。

核心结论

  • 嗅裂黏液EDN水平可能是比血嗜酸性粒细胞计数更好的预测CRS嗅觉障碍的生物标志物。

研究设计与样本

  • 前瞻性研究纳入150例接受内镜鼻窦手术的CRS患者和25例健康对照,收集上鼻甲活检标本与嗅裂黏液检测EDN水平,并行Sniffin' Sticks测试、嗅裂CT评分和OCES评估。

主要发现

  • 伴嗅觉障碍的CRS患者嗅黏膜EDN水平显著高于无嗅觉障碍者(P=0.016),嗅裂黏液EDN水平也显著更高(P<0.001)。
  • CRS患者黏液EDN与血嗜酸性粒细胞(r=0.625,P=0.002)、嗅裂CT评分(r=0.738,P<0.001)、OCES(r=0.605,P=0.004)呈正相关。
  • 黏液EDN与TDI(r=-0.688)、嗅觉阈值(r=-0.606)、嗅觉辨别(r=-0.608)、嗅觉识别(r=-0.697)评分呈显著负相关。
  • 校正人口学与共病后,黏液EDN水平与CRS嗅觉障碍显著相关(OR=2.162,P=0.027)。
  • 黏液EDN预测嗅觉障碍的AUC为0.873,血嗜酸性粒细胞计数为0.764,两者差异显著(P=0.024)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Eosinophils are associated with olfactory dysfunction in chronic rhinosinusitis (CRS) and eosinophil-derived neurotoxin (EDN) is a sensitive marker of intense eosinophil activation. This study aimed to analyze olfactory cleft mucus and olfactory mucosa EDN levels and their association with olfactory dysfunction in CRS. METHODS: We prospectively recruited 150 patients with CRS electing endoscopic sinus surgery and 25 healthy controls. Both superior turbinate biopsy specimens and olfactory cleft mucus were collected to analyze EDN levels. Sniffin' Sticks test scores, olfactory cleft computed tomography (CT) scores, and olfactory cleft endoscopy scale (OCES) were obtained. Multivariable logistic regression analysis was applied to analyze the predictability of EDN levels for olfactory dysfunction in CRS. RESULTS: Chronic rhinosinusitis with olfactory dysfunction presented significantly higher olfactory mucosa (p = 0.016) and olfactory cleft mucus (p < 0.001) EDN levels than CRS without olfactory dysfunction. Mucus EDN levels were positively correlated with blood eosinophils (r = 0.625, p = 0.002), olfactory cleft CT scores (r = 0.738, p < 0.001), and OCES (r = 0.605, p = 0.004) in CRS. Furthermore, mucus EDN levels were significantly negatively correlated with threshold, discrimination, and identification (TDI) (r = -0.688), olfactory threshold (r = -0.606), olfactory discrimination (r = -0.608), and olfactory identification (r = -0.697) scores. After adjusting for patient demographics and comorbidities, mucus EDN levels were significantly associated with olfactory dysfunction in CRS (odds ratio = 2.162; p = 0.027). Mucus EDN levels showed a significantly better performance for predicting olfactory dysfunction than blood eosinophil counts (area under the curve, 0.873 vs. 0.764, p = 0.024). CONCLUSION: Olfactory cleft mucus EDN level may be a better biomarker for predicting olfactory dysfunction in CRS than blood eosinophil counts.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Wu D, Liu Z, Bleier BS, et al. Olfactory cleft mucus eosinophil-derived neurotoxin better reflects olfactory loss than blood eosinophil counts in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2023. PMID: 37264735. doi:10.1002/alr.23202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。